Paul Lehr
General Counsel at LONGEVERON INC.
Net worth: 13 303 $ as of 2024-05-30
Paul Lehr active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LONGEVERON INC. | General Counsel | 2015-12-31 | - |
| Corporate Secretary | 2015-12-31 | - | |
| Groundupmusic | Director/Board Member | 2014-12-31 | - |
Heart Genomics LLC
 Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Chief Executive Officer | 2010-12-31 | - |
| Founder | 2010-12-31 | - |
Career history of Paul Lehr
Training of Paul Lehr
| Brown University | Undergraduate Degree |
| University of Florida Levin College of Law | Graduate Degree |
Statistics
International
| United States | 5 |
| 2 |
Operational
| General Counsel | 1 |
| Corporate Secretary | 1 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
| Longeveron, Inc. | |
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Heart Genomics LLC is a biotechnology company that specializes in developing and commercializing non-invasive, genomic-based clinical diagnostic tests for patients with heart disease or heart failure. Heart Genomics is based in Miami Beach, FL. The private company's diagnostic tests provide personalized and individualized information to each patient and their physician through genomic analysis of the patient's heart tissue or blood sample. This information helps the heart patient and physician make substantially improved and clear treatment decisions. The company was founded by Paul Lehr and Joshua M. Hare, and Paul Lehr has been the CEO since incorporation. | Commercial Services |
| Groundupmusic |
- Stock Market
- Insiders
- Paul Lehr
- Experience
